Binding of ApoE isoforms to Aβ peptides and effects on their fibrillization
Authors:
Preprint
- 12 November 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Alzheimer’s disease (AD) is the most widespread neurodegenerative disease, strongly linked to amyloid depositions in the brain consisting of amyloid beta (Aβ) peptides. The likelihood of developing late-onset Alzheimer’s disease (LOAD) is influenced by the specific isoforms of apolipoprotein E (ApoE), with ApoE4 being the strongest known genetic risk factor for LOAD. Strong evidence suggests that ApoE impacts AD by modulating Aβ aggregation and clearance, although the precise molecular mechanisms remain incompletely understood. Microscale thermophoresis (MST) is a powerful technique for characterizing molecular interactions in solution, which has been used to determine various binding constants, although not the binding of ApoE to Aβ peptides. MST results show that ApoE isoforms bind Aβ1–40 and Aβ1–42 with low micromolar affinity. For Aβ1–42, ApoE3 shows the strongest binding (K d = 0.72 µM) and ApoE4 the weakest (K d = 2.80 µM). For Aβ1–40, ApoE4 shows the strongest binding (K d = 1.59 µM) and ApoE2 the weakest (K d = 5.29 µM). The MST results show that ApoE interacts with Aβ peptides at supraphysiological peptide concentrations. However, ApoE inhibited the fibrillization of Aβ1–40 peptide at sub-stoichiometric concentrations, which might be related to blocking Aβ fibril elongation in vivo. The estimated IC 50 values indicate that ApoE4 has slightly stronger and ApoE2 has the lowest inhibitory effect on Aβ1–42 fibrillization.Keywords
All Related Versions
This publication has 30 references indexed in Scilit:
- The LDL Receptor-Related Protein 1: Mechanisms and roles in promoting Aβ efflux transporter in Alzheimer’s diseaseBiochemical Pharmacology, 2024
- Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s diseaseNature Communications, 2024
- Microscale thermophoresis (MST) and spectral shift (SpS) in drug discoveryTrAC Trends in Analytical Chemistry, 2024
- APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s diseaseSeminars in Immunology, 2022
- Real-Time Analysis of Specific Binding between Apolipoprotein E Isoforms and Amyloid β-Peptide by Dual Polarization InterferometryAnalytical Chemistry, 2020
- APOE-amyloid interaction: Therapeutic targetsNeurobiology of Disease, 2020
- Binding of Human Proteins to Amyloid-β ProtofibrilsACS Chemical Biology, 2014
- The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid AggregationBiochemistry, 2014
- Cu(II) Affinity for the Alzheimer’s Peptide: Tyrosine Fluorescence Studies RevisitedAnalytical Chemistry, 2012
- A Synthetic Peptide Blocking the Apolipoprotein E/β-Amyloid Binding Mitigates β-Amyloid Toxicity and Fibril Formation in Vitro and Reduces β-Amyloid Plaques in Transgenic MiceThe American Journal of Pathology, 2004